ArticleGland surgery2024

Neoadjuvant T-DM1 for HER2-positive breast cancer used as a bridging strategy during COVID-19 pandemic: lessons learned-a case series.

Adrian Choppa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.